IMAGE Skincare expands IMAGE MD medical-grade line with NAD+ biotech crème, barrier repair balm and cleansing balm

Key Highlights
Introduction
What the new IMAGE MD® products are designed to do
Product deep dive: biotech longevity crème
Product deep dive: barrier recovery balm
Product deep dive: gentle cleansing balm
Post Treatment Essentials Kit: combining convenience and compliance
Clinical reasoning: how these products fit into post-procedure timelines
Ingredient science in context: what the actives do and what to expect
Seals of acceptance and clinical validation: what they mean for providers and consumers
Integrating IMAGE MD® into clinical practice
Market context: why medical-grade and post-procedure products matter now
Real-world examples: patient scenarios and outcomes
Consumer safety and labeling considerations
Practical shopping and availability
What clinicians should ask when evaluating these products
Consumer guidance: how to use IMAGE MD® items safely and effectively
Limitations and transparency
Availability and where to buy
FAQ

Key Highlights

IMAGE Skincare launches three IMAGE MD® medical-grade formulations—biotech longevity crème, barrier recovery balm and gentle cleansing balm—targeting post-procedure recovery and long-term anti‑aging support.
New formulas emphasize barrier restoration, inflammation control and cellular resilience via an NAD+ booster, patent-pending XOSM™ Technology and clinically validated soothing actives; Post Treatment Essentials Kit available at $54.

Introduction

Professional skin treatments such as laser resurfacing, chemical peels and microneedling deliver dramatic results, but the period immediately after a procedure often determines both recovery speed and the longevity of benefits. IMAGE Skincare’s expanded IMAGE MD® collection arrives with a clear focus on that window: products designed to defend, soothe and restore skin compromised by procedures or sensitivity. The three additions—a biotech longevity crème, a barrier recovery balm and a gentle cleansing balm—pair targeted actives with textures formulated for comfort and compliance. A compact Post Treatment Essentials Kit bundles these items for early post-procedure care and daily maintenance.

The new launches aim to bridge the gap between clinical treatment and home care, offering formulations marketed as medical-grade and clinically proven. Understanding how these products work, why their ingredients matter for recovery and how professionals can integrate them into treatment protocols helps clinicians and consumers make informed choices about post-procedure regimens.

What the new IMAGE MD® products are designed to do

IMAGE Skincare positions the IMAGE MD® additions around three overlapping goals: protect, soothe and restore. Protection refers not only to shielding skin from environmental stressors but also to supporting cellular systems that deteriorate with age. Soothing targets immediate inflammation and discomfort that follows resurfacing or irritation. Restore means rebuilding the skin’s barrier—the lipid matrix that prevents moisture loss and defends against external irritants—and promoting tissue repair mechanisms to return the skin to healthy function.

The collection addresses these goals through complementary deliverables:

A biotech longevity crème aimed at long-term resilience and visible signs of aging using an NAD+ booster and XOSM™ Technology.
A barrier recovery balm that mimics the skin’s lipid composition and provides semi-occlusive moisture with clinically accepted soothing ingredients.
A gentle cleansing balm that removes impurities without stripping or disrupting the recovering barrier, formulated to leave skin soft and soothed.

Together they target both immediate post-procedure needs—comfort, hydration, reduced inflammation—and ongoing maintenance to support repair processes and reduce the recurrence of visible aging signs.

Product deep dive: biotech longevity crème

The IMAGE MD® biotech longevity crème is positioned as a next-generation treatment intended to enhance skin vitality over time. Core features cited by the brand include an NAD+ booster, anti-inflammatory properties and proprietary XOSM™ Technology.

NAD+ and cellular repair Nicotinamide adenine dinucleotide (NAD+) is a coenzyme central to cellular metabolism and the activity of sirtuin proteins, which regulate DNA repair, mitochondrial function and oxidative stress responses. NAD+ levels decline with age in many tissues, and reduced availability is associated with diminished cellular repair capacity. Formulations that include NAD+ precursors or boosters aim to support these metabolic pathways, promoting improved cellular resilience and more effective repair of daily microdamage. When combined with anti-inflammatory actives and antioxidants, an NAD+ booster in a topical product seeks to create a favorable environment for tissue restoration and reduction of visible aging signs such as fine lines, rough texture and age spots.

Texture, delivery and XOSM™ Technology IMAGE’s biotech crème leverages XOSM™ Technology, a named proprietary system the company says enhances ingredient performance. Brand-owned delivery technologies typically aim to improve active stability, skin penetration or release profiles. Enhanced delivery can increase the bioavailability of sensitive molecules—such as NAD+ precursors or other actives—in topical applications, leading to stronger clinical outcomes compared with poorly delivered ingredients. The biotech crème is described as next-generation and targets cumulative repair and protection, implying both immediate skin benefits and longer-term improvements in skin quality.

Clinical claims and expectations The press materials label the formula “clinically proven,” which in consumer skincare typically references internal clinical trials or instrument-assessed outcomes such as transepidermal water loss (TEWL), wrinkle depth, pigmentation measurements or expert grading. For clinicians and informed consumers, clinically proven treatments are more persuasive when details about study design—sample size, assessment methods and statistical significance—are available. In practice, clinicians incorporate such products into protocols to support tissue repair and extend treatment benefits; patients often notice improved texture and hydration within days to weeks, with pigment and wrinkle improvements emerging across months of consistent use.

Applicability This crème targets patients seeking an evidence-forward anti-aging step that also supports resilience after procedures. Its place in a regimen can be as a daily restorative cream applied after cleansing and barrier treatments or, for post-procedure care, as a next-step product once the initial acute inflammatory phase has subsided and professional guidance allows resumption of advanced actives.

Product deep dive: barrier recovery balm

Restoring the skin’s barrier is the primary objective of the IMAGE MD® barrier recovery balm. The brand emphasizes that the balm “mimics the skin’s natural lipid barrier composition,” uses a semi-occlusive silk-like formula and carries seals of acceptance from the National Rosacea Society and the National Eczema Association.

Why the lipid barrier matters The outermost skin layer—stratum corneum—is a structured matrix of corneocytes embedded in a lipid mixture made up primarily of ceramides, cholesterol and free fatty acids. This “brick and mortar” system prevents excessive water loss and blocks penetration of irritants and pathogens. When professional procedures disrupt that matrix—common after deeper peels, ablative lasers and aggressive resurfacing—skin becomes red, flaky and more vulnerable to infection and irritation. Restoring the lipid balance speeds re-epithelialization, reduces TEWL and improves comfort.

Semi-occlusive vs occlusive The balm is described as semi-occlusive. Occlusive products (like petrolatum) create a nearly impervious layer that locks in moisture but can feel heavy and may trap heat or exudate in highly compromised wounds. Semi-occlusive formulations form a protective film that reduces water loss while permitting limited gas exchange and moisture release; this balance supports moist wound healing without the drawbacks of full occlusion in certain clinical scenarios. For post-procedure use, especially where exudation and swelling are present, semi-occlusive formulations often provide optimal healing conditions.

Key soothing ingredients IMAGE’s balm incorporates beta-glucan, colloidal oatmeal and a 3-in-1 hydration complex.

Beta-glucan: a polysaccharide derived from yeast, oats or fungi; it modulates immune responses in the skin and accelerates wound healing by stimulating collagen production and keratinocyte migration. Clinically, beta-glucan reduces erythema and improves skin texture when applied to compromised tissue.
Colloidal oatmeal: a centuries-old topical ingredient recognized for its ability to soothe itching and irritation, regulate barrier lipids and stabilize the skin surface. The FDA and dermatology literature acknowledge colloidal oatmeal’s utility for atopic dermatitis and irritation-prone skin.
3-in-1 hydration complex: while the brand does not enumerate the three parts in the press release, complexes of this name typically combine humectants (e.g., glycerin, hyaluronic acid), emollients (e.g., fatty acids, esters) and occlusives to provide layered hydration—drawing water to the skin, smoothing the lipid matrix and preventing evaporation.

Clinical acceptance seals The balm’s seals of acceptance from the National Rosacea Society and the National Eczema Association represent recognition that the product’s formulation is appropriate for people with rosacea or eczema-prone skin. These organizations evaluate formulations for ingredient safety, low-irritant potential and absence of common triggers. For clinicians, a product carrying these seals is easier to recommend to sensitive, reactive patients or to those with preexisting inflammatory conditions.

Practical application Clinicians commonly recommend barrier-focused balms immediately after procedures where the lipid matrix is compromised. Typical steps:

Cleanse with an ultra-gentle product to remove debris.
Apply a thin layer of barrier balm several times daily to maintain moisture and comfort.
Reserve more active anti-aging ingredients for later phases of healing as tolerated.

The balm’s silky, semi-occlusive character suits both daily maintenance and short-term post-procedure intervention.

Product deep dive: gentle cleansing balm

A compromised barrier requires a cleanser that removes surface residue without further stripping natural lipids. IMAGE MD® gentle cleansing balm responds to that need with a balm-to-milk texture built around grapeseed oil, chamomile, vanilla and a phyto antioxidant blend.

Balm-to-milk chemistry and benefits Balm cleansers rely on oil-based bases that dissolve oil-soluble impurities—sunscreen, pigment, sebum and lipid-encased debris—effectively and gently. When water is added, emulsifiers in the formulation convert the balm into a milky rinse that lifts away dissolved impurities without leaving a heavy residue. This action minimizes friction and mechanical irritation, an important consideration for recovering skin.

Ingredient advantages

Grapeseed oil: a light, fast-absorbing oil rich in linoleic acid and antioxidants. Its emollient properties help restore lipid balance without producing heavy occlusion.
Chamomile: known for anti-inflammatory and soothing properties; contains bisabolol and apigenin, compounds that can calm irritated skin.
Phyto antioxidant blend: plant-derived antioxidants neutralize free radicals generated by UV exposure and inflammation, reducing oxidative stress that can prolong recovery and worsen pigmentation.

Post-procedure cleansing protocol After procedures, cleansing protocols prioritize:

Gentle removal of residue and topical product build-up without disrupting re-epithelializing tissue.
Avoidance of surfactants that strip lipids.
Use of lukewarm water and minimal rubbing.

A balm-to-milk cleanser applied with gentle circular motions, then emulsified and rinsed, meets these criteria and supports patient comfort while maintaining hygiene.

Post Treatment Essentials Kit: combining convenience and compliance

IMAGE Skincare’s Post Treatment Essentials Kit ($54) bundles travel sizes of the gentle cleansing balm (1 oz), barrier recovery balm (0.5 oz) and a 1-oz mineral SPF moisturizer. Kits fill a practical role for clinicians and patients alike: they simplify immediate post-procedure recommendations, reduce confusion about product order and provide enough supply for the critical first days of recovery.

Why a kit matters Patients often leave procedures with patchwork instructions and inconsistent supplies. A curated kit shortens the time to effective care and reduces the likelihood that a patient will substitute inappropriate products—like harsh foaming cleansers or fragranced lotions—that impede healing. Including a mineral SPF underscores sunscreen’s central role: protecting newly repaired skin from UV-driven hyperpigmentation and further damage.

Clinical scenarios where the kit is useful

After a medium-strength chemical peel: use the cleansing balm morning and night, thin applications of barrier balm throughout the day as needed, and mineral SPF during daytime hours.
Following non-ablative laser treatments: begin with the cleansing balm within 24 hours if permitted by the clinician, apply barrier balm to comfort, and use SPF outdoors.
For microneedling: cleansers and barrier balms support the recovery period of 24–72 hours; mineral sunscreen becomes essential once the barrier begins to reseal.

Kits provide a low-friction way for practices to retail recommended regimens at point-of-care.

Clinical reasoning: how these products fit into post-procedure timelines

Immediate post-procedure (first 24–72 hours) The priority is to minimize infection risk, control inflammation and maintain a moist environment conducive to epithelial migration. Clinically, this often means gentle cleansing (if allowed), frequent application of barrier-supportive emollients and avoidance of active retinoids or chemical exfoliants. For many procedures, a semi-occlusive barrier balm applied in thin layers satisfies these needs without risking occlusion-related complications.

Early recovery phase (3–14 days) Erythema and peeling decline and barrier function restores gradually. Practitioners typically continue gentle cleansing and barrier support. If no contraindications exist, introducing restorative creams aimed at cellular repair—such as the biotech longevity crème—becomes reasonable in this phase. Antioxidants and NAD+ boosters can support repair pathways and mitigate oxidative stress, while SPF is non-negotiable outdoors.

Late recovery and maintenance (2 weeks+) Once the barrier is largely intact and the skin tolerates more active ingredients, clinicians may layer in targeted actives—retinoids, vitamin C formulations and procedures—guided by patient tolerance and long-term goals. The biotech crème’s emphasis on longevity makes it suitable for daily use in maintenance routines, while the cleansing balm and barrier balm can remain staples during flare-ups or seasonally dry periods.

Case example A patient undergoes fractional laser resurfacing for photodamage. The clinician instructs immediate post-procedure care: soft gauze for 6–12 hours, then gentle cleansing with a balm if crusting is minimal. The patient applies a thin layer of the barrier balm every 4–6 hours for the first week and uses the included mineral SPF during daytime. After seven days, the clinician clears the patient to begin applying the biotech longevity crème nightly to support collagen synthesis, pairing it with continued daytime mineral SPF.

Ingredient science in context: what the actives do and what to expect

NAD+ boosters and longevity claims Topical NAD+ boosters aim to provide precursors that support intracellular NAD+ pools. When adequately delivered, these precursors can enhance mitochondrial function and sirtuin activity, which associate with DNA repair and stress resistance. Realistic expectations: improvements in skin texture, subtle reduction in fine lines and enhanced radiance over months; dramatic wrinkle reversal typically requires procedural intervention or prescription therapies.

Beta-glucan, colloidal oatmeal and barrier repair These ingredients bring immediate symptomatic relief—less itching, reduced scaling and improved comfort—while supporting the barrier’s biochemical repair processes. Patients typically notice reduced sensation of tightness and decreased redness within days; full normalization of barrier metrics can take weeks, depending on procedure depth.

Antioxidants and phyto actives Plant antioxidants neutralize reactive oxygen species and blunt the inflammatory cascade. This action reduces long-term pigmentary sequelae and supports collagen preservation. Antioxidant efficacy depends on concentration, stability and delivery; proprietary technologies like XOSM™ can improve those parameters.

Texture and compliance Patient adherence correlates with sensorial profile. A silky balm feels pleasant and is more likely to be used multiple times per day than a greasy ointment. A balm-to-milk cleanser that rinses clean helps patients maintain hygiene without the sting or dryness that accompanies many foaming cleansers. Practical compliance translates directly to better outcomes.

Seals of acceptance and clinical validation: what they mean for providers and consumers

National Rosacea Society and National Eczema Association seals These seals indicate that a formulation has undergone review for suitability in people with rosacea or eczema. While they are not clinical efficacy certifications, they reduce the risk that a product will exacerbate underlying inflammatory skin diseases. For clinicians, the presence of these seals eases the decision to recommend these products to sensitive patients. For consumers, the seals serve as a trustworthy shorthand for low-irritation formulations.

“Clinically proven” in marketing vs. peer-reviewed evidence Brands commonly use “clinically proven” when internal studies demonstrate measurable benefits. However, transparency about study parameters—randomization, blinding, controls and objective endpoints—matters for critical appraisal. Providers should request study summaries when considering inclusion in practice protocols. Absent full peer-reviewed publications, reputable clinician reviews and practical experience in the clinic supplement decision-making.

Real-world relevance Products that combine favorable clinical testing, appropriate seals and practical textures tend to be adopted more rapidly in professional settings. IMAGE Skincare reports widespread professional acceptance—over 50,000 skin experts across 60 countries—and market leadership in the spa and salon category per Kline & Co. These measures reflect distribution reach and practitioner familiarity, both of which influence patient access and compliance.

Integrating IMAGE MD® into clinical practice

Point-of-care retail and patient education Clinicians frequently bundle immediate post-treatment products with procedures. A recommended workflow:

At consultation, outline the recovery plan and preview the post-procedure kit.
At the time of treatment, provide the kit and hands-on instruction: how to cleanse, how much balm to apply, how often, and an SPF reapplication schedule.
Schedule a follow-up within the first week to assess barrier recovery and adjust regimen.

Protocol examples by procedure

Microdermabrasion and light peels: cleansing balm twice daily, barrier balm as needed, mineral SPF for daytime.
Medium chemical peels: cleansing balm once daily if tolerated, barrier balm at frequent intervals, biotech crème introduced by day 7–10 under clinician guidance.
Ablative lasers: clinician-dependent; use of barrier balm tailored to exudation and clinician instructions; biotech crème typically delayed until significant re-epithelialization occurs.

Managing complications and sensitivity If a patient exhibits excessive redness, prolonged oozing or signs of infection, clinicians should pause topical cosmeceuticals and manage according to wound care protocols. For mild prolonged erythema or flaking, continue barrier support and consider adding anti-inflammatory topical agents under medical supervision.

Training and adoption Clinics that integrate new lines often benefit from staff training provided by the brand—product science, demonstration of textures and suggested scripts for patient counseling. Such education improves the likelihood patients will use and adhere to prescribed regimens.

Market context: why medical-grade and post-procedure products matter now

Professional skincare demand and differentiated formulations Patients increasingly seek treatment outcomes that combine the speed and efficacy of in-office procedures with sustained home-care strategies that maintain results and reduce downtime. Medical-grade lines occupy a middle ground between prescription medications and over-the-counter cosmetics, promising higher concentrations of actives, targeted delivery systems and clinical testing.

Brands that partner with estheticians and dermatology practices win visibility at the point of care. IMAGE Skincare’s growth since 2003—starting from an esthetician-founded company to a global brand—reflects consumers’ appetite for clinically oriented but accessible home-care products. Professional endorsements and a presence in thousands of clinics create a feedback loop: clinicians recommend products they trust, patients see results, and retail adoption increases.

Competitive landscape Other medical-grade lines have emphasized barrier repair and post-procedure care in recent years. The distinguishing factors for clinics are active choice (which molecular targets a brand pursues), delivery technology, clinical evidence and sensorial profiles. IMAGE MD®’s emphasis on NAD+ boosting and XOSM™ Technology positions it distinctively among barrier-focused launches, though clinicians will evaluate whether these innovations translate into measurable clinical advantages relative to existing standards.

Consumer behavior and compliance Product textures, kits and point-of-care availability influence adherence. Patients facing downtime prioritize comfort and simplicity; a three-product kit that covers cleansing, barrier support and sun protection reduces barriers to correct use. The inclusion of a mineral SPF is especially important because newly treated skin is prone to hyperpigmentation when exposed to UV radiation.

Real-world examples: patient scenarios and outcomes

Case 1: Reactive, thin-dermis individual undergoing light chemical peel A 45-year-old patient with a history of rosacea undergoes a light TCA peel for superficial photodamage. The clinician selects a conservative approach and prescribes the Post Treatment Essentials Kit. The patient uses the cleansing balm sparingly the evening after the peel, applies barrier balm three times daily for the first ten days, and uses the mineral SPF during the day. The patient reports diminished tightness within 48 hours, reduced flaking by day 6 and reintroduction of the biotech longevity crème at week 3. At three months, skin texture improves and erythema is well controlled.

Case 2: Microneedling for acne scarring on oily skin A 32-year-old with mixed-to-oily skin undergoes microneedling. The clinician suggests the gentle cleansing balm for morning and evening cleansing and the barrier balm initially only at night to minimize excess shine. By day 5, the barrier feels restored and the patient starts nightly application of the biotech crème. Acneiform flares do not occur; post-inflammatory hyperpigmentation is limited by consistent mineral sunscreen use.

Case 3: Fractional CO2 resurfacing for deep rhytides After an ablative fractional CO2 session, the clinician emphasizes controlled wound care. For the first several days, the patient uses clinician-provided dressing and, when cleared, transitions to the barrier balm as the primary topical. The cleansing balm is deferred until the clinician deems crusting resolved. The biotech crème is held until epithelialization is sufficient, then introduced to help support collagen remodeling. Outcomes include predictable re-epithelialization and satisfaction with long-term texture improvement.

These cases illustrate practical decision points: timing of product introduction, frequency of barrier applications and the role of SPF in preventing pigmentary complications.

Consumer safety and labeling considerations

Patch testing and sensitive skin Even low-irritant products can provoke reactions in highly sensitive individuals. For patients with severe allergy histories, perform patch testing or recommend trial sizes. Balm and milk-based formulations are often better tolerated than alcohol-based tonics or strong surfactants.

Fragrance and botanicals The inclusion of vanilla and plant-derived antioxidant blends offers sensory appeal but can present allergenicity in some users. The National Rosacea Society and NEA seals imply a low fragrance profile or careful selection of sensitizing ingredients, but clinicians should ask about fragrance sensitivity before recommending.

Regulatory context IMAGE Skincare markets these as “medical-grade” and “clinically proven.” These designations differ from prescription-only status and do not equate to FDA-approved drug claims. Topical cosmeceuticals can be clinically evaluated and sold through professional channels without the regulatory requirements of pharmaceuticals, but claims must avoid disease treatment language.

Practical shopping and availability

Distribution channels The IMAGE MD® collection will be offered through professional spas and salons, and direct-to-consumer via imageskincare.com. For practices, carrying the line supports patient access and creates a revenue stream through point-of-care retail.

Kit pricing and value At $54, the Post Treatment Essentials Kit provides an entry-point price for patients seeking immediate post-procedure care. Travel-size packaging incentivizes trial and reduces waste for clinicians who want to ensure patients have the immediate tools for recovery.

Global presence and professional adoption IMAGE’s reported presence in 60 countries and use by over 50,000 skin experts reflects broad adoption. For clinicians considering adding IMAGE MD® to formulary options, local distributor relationships and training support influence the ease of integration.

What clinicians should ask when evaluating these products

What objective clinical data supports the “clinically proven” claim? Request study protocols and endpoints.
How does XOSM™ Technology enhance delivery compared with other platforms? Seek mechanistic summaries or comparative data.
Are there known sensitivities or contraindications for the product ingredients?
How do textures and packaging support patient adherence?
Does the brand provide staff training and point-of-care materials for retailing?

Asking these questions helps clinicians assess whether the line fits their patient population and treatment philosophy.

Consumer guidance: how to use IMAGE MD® items safely and effectively

Cleansing balm

Use morning and night as tolerated, applying a small amount to dry skin.
Gently massage to dissolve makeup and debris, add water to emulsify, then rinse with lukewarm water.
Avoid aggressive rubbing or exfoliation during the first week after moderate-to-deep procedures.

Barrier recovery balm

Apply thin layers to moist or slightly damp skin for optimal absorption and barrier sealing.
Reapply several times daily if tolerated; do not over-occlude heavily exuding wounds; follow clinician instructions for open wounds or significant exudate.
Continue use until barrier function returns to baseline or as directed by a practitioner.

Biotech longevity crème

Start once the acute inflammatory and wound phases have subsided, typically days to weeks depending on the procedure depth.
Use nightly or as directed; pair with daytime mineral SPF.
Monitor for irritation and discontinue if undue redness or stinging occurs.

Sun protection

Mineral SPF inclusion in the kit emphasizes physical blockers like zinc oxide or titanium dioxide, which are less irritating to compromised skin.
Reapply every two hours when outdoors and after sweating or towel drying.

When to contact your clinician

Excessive pain, swelling, fever or sudden increase in drainage suggests infection—seek medical attention.
If expected recovery stalls or if pigmentation changes accelerate, consult the treating clinician for assessment.

Limitations and transparency

No topical product alone replaces procedural modalities for certain conditions. While actives like NAD+ boosters and barrier-supportive ingredients can support recovery and visible outcomes, deeper rhytides and extensive photodamage often require a combination of procedures and disciplined home care. Clinicians should set realistic expectations with patients: topical regimens enhance and maintain results, reduce complications, and improve comfort, but they are part of a broader therapeutic plan.

Additionally, transparency about the nature of clinical data strengthens trust. Clinicians can request detailed study summaries from IMAGE Skincare to better appraise the strength of evidence behind clinical claims.

Availability and where to buy

IMAGE MD® will be available at professional spas and salons and directly through imageskincare.com. The Post Treatment Essentials Kit retails for $54 and contains travel-sized products tailored to immediate post-procedure needs. For practices wishing to stock and resell the line, contacting the brand’s professional sales channels can provide access to wholesale pricing, staff education and marketing materials.

FAQ

Q: Who are these IMAGE MD® products intended for? A: The IMAGE MD® biotech longevity crème, barrier recovery balm and gentle cleansing balm target individuals undergoing professional treatments (laser, chemical peels, microneedling), those with sensitive or compromised skin, and patients seeking a clinically oriented anti-aging maintenance routine. Products carrying National Rosacea Society and National Eczema Association seals are especially relevant to patients with rosacea or eczema-prone skin.

Q: When should each product be used after a procedure? A: Immediate post-procedure care emphasizes gentle cleansing and barrier support. The gentle cleansing balm can be used within 24–48 hours when clinician clearance indicates minimal crusting and no open wounds. The barrier recovery balm is typically applied immediately to support moisture and comfort; frequency depends on exudation and clinician guidance. The biotech longevity crème is generally introduced later in the early recovery phase, once significant re-epithelialization has occurred, to support collagen remodeling and cellular repair.

Q: What is an NAD+ booster, and why is it included? A: NAD+ is a coenzyme involved in cellular metabolism, DNA repair and mitochondrial function. Topical NAD+ boosters aim to support these cellular pathways to improve resilience and tissue repair. In the context of skin care, supporting NAD+ levels may help reduce signs of aging and support recovery after procedures. Results depend on formulation, delivery and consistent use.

Q: What does XOSM™ Technology mean? A: XOSM™ Technology is IMAGE Skincare’s proprietary delivery platform intended to enhance the performance of active ingredients. While specific mechanisms are proprietary, such technologies typically focus on stabilizing actives, improving skin penetration and optimizing release profiles to increase clinical effectiveness.

Q: What is the difference between semi-occlusive and occlusive products? A: Occlusive products create an impermeable barrier that locks in moisture (e.g., petrolatum). Semi-occlusive formulations reduce moisture loss while permitting some gas exchange and are often preferable in wound healing because they maintain a moist environment without excessive sealing that might trap exudate.

Q: Are these products safe for people with rosacea or eczema? A: The barrier recovery balm carries seals of acceptance from the National Rosacea Society and the National Eczema Association, indicating the formulation has been evaluated for suitability in such conditions. However, individuals with severe or unstable disease should consult a clinician before use.

Q: Can these items replace prescription post-procedure medications? A: No. These topical formulations support recovery and comfort but do not substitute for prescribed medical therapies when those are indicated. Follow clinician instructions regarding antibiotics, steroids or other prescription agents.

Q: Where can patients buy the products? A: The IMAGE MD® collection is available at professional spas, salons and through imageskincare.com. The Post Treatment Essentials Kit retails for $54 and includes travel sizes of the three key products.

Q: How long before I see visible improvements? A: Comfort and hydration typically improve within days. Texture smoothing and reductions in fine lines or pigmentary changes occur progressively over weeks to months, depending on baseline condition, procedure depth and consistent product use.

Q: Should patients patch-test these products first? A: Patch testing is prudent for patients with known sensitivities or severe atopic histories. For most users, trial sizes and small-area testing reduce the risk of adverse reactions.

Q: Are these products suitable for everyday use? A: The cleansing balm and barrier balm are appropriate for regular use, including daily cleansing and ongoing barrier support. The biotech longevity crème is designed for routine anti‑aging use once the skin tolerates advanced actives, typically after the acute post-procedure phase.

Q: What do clinicians need to know before recommending these products? A: Clinicians should review clinical study summaries, understand timing for post-procedure introduction, be aware of ingredient profiles for allergy potential and instruct patients on correct application frequency and sunscreen use.

Q: Do these products contain fragrance or potential irritants? A: The cleansing balm includes vanilla and a phyto antioxidant blend for sensory and antioxidant benefits. While the balm and recovery formula carry seals indicating low-irritation profiles, patients sensitive to fragrance should discuss tolerability and consider patch testing.

Q: How do these launches position IMAGE Skincare in the professional market? A: The IMAGE MD® additions strengthen IMAGE Skincare’s medical-grade offerings and align with trends prioritizing barrier restoration and cellular-level anti-aging. The combination of clinical claims, proprietary technology and professional distribution can reinforce adoption in spa and salon settings.

Q: What should patients do if they experience worsening redness, pain or drainage? A: Contact the treating clinician immediately. These signs may indicate infection or an adverse reaction requiring medical intervention.

This report synthesizes the features and clinical rationale behind IMAGE Skincare’s IMAGE MD® expansions: a biotech longevity crème with an NAD+ booster and delivery technology, a barrier recovery balm formulated to mimic natural lipids and supported by national seals, and a gentle balm-to-milk cleanser designed for post-procedure tolerance. For clinicians and patients, the line promises practical textures, targeted actives and convenient kit options to support recovery and long-term treatment outcomes.